- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00621569
ADAPT-Altering Diet for African American Populations to Treat Hypertension (ADAPT)
March 15, 2013 updated by: Jamy Ard, MD, University of Alabama at Birmingham
A Culturally Appropriate Intervention in Hypertensive African-Americans Based on the DASH Diet-The ADAPT Hypertension Study = Altering Diet for African American Populations to Treat Hypertension
The purpose of the study is to develop a culturally appropriate DASH intervention and test the effectiveness of the intervention lower blood pressure in a group of African American participants at risk for developing hypertension (pre-hypertension) and those with mild hypertension (stage I).
Study Overview
Status
Completed
Conditions
Detailed Description
The effectiveness of the Dietary Approaches to Stop Hypertension (DASH) diet has shown to have limited impact on blood pressure control among African Americans, which might be explained by inappropriate adaptation to African American culture and tradition.
Therefore, the adequate adaptation of the DASH diet would result in blood pressure control among African-Americans.
Using the nominal group technique as a part of the formative assessment, this project proposes to identify key cultural variables that impact dietary patterns for African Americans.
Based on those results, a modified behavioral intervention will be developed and tested in African Americans with pre-hypertension or stage I hypertension.
Primary outcomes will include change in systolic and diastolic blood pressure at six months.
It is expected that this project will contribute an additional tool for physicians, patients and health care systems to improve hypertension control amongst African Americans.
The specific aims for this dietary intervention are: (1) to develop a modified DASH dietary pattern that is culturally appropriate for African-Americans by using principals of formative analysis and (2) to conduct a randomized, controlled trial to determine the effectiveness of the modified DASH dietary pattern in reducing blood pressure for a cohort of African-Americans with pre-hypertension or stage I hypertension to a usual care control group.
Study Type
Interventional
Enrollment (Actual)
122
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294-3360
- University of Alabama at Birmingham Department of Nutrition Sciences
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Baseline SBP 120-159 mmHg and DBP 80-95 mmHg
- Age 25 or older as of the initial screening visit
- Willing and able to participate fully in all aspects of the intervention
- Not on rigid diet
- Provide informed consent
- BMI 18.5-45 kg/m2
Exclusion Criteria:
- Regular use of anti-hypertensive drugs or other drugs that raise or lower BP (any in previous three months)
- Current use of insulin or oral hypoglycemic agents
- Use of oral corticosteroids >5 days/month on average
- Current use of medications for treatment of psychosis or manic-depressive illness
- Use of oral breathing medications other than inhalers > 5 days/month on average
- Use of weight-loss medications in previous 3 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: 1
Group intervention with no dietary focus
|
Participants receive information regarding useful life skills in a group setting
|
|
EXPERIMENTAL: 2
DASH diet intervention
|
The purpose of this study is to create a culturally appropriate diet to test the effectiveness of the intervention to lower blood pressure in a grou pof African American individuals at risk for developing hypertension (pre-hypertension) and those with mild hypertension (stage I).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in blood pressure with dietary intervention
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in weight
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2005
Primary Completion (ACTUAL)
July 1, 2008
Study Completion (ACTUAL)
December 1, 2011
Study Registration Dates
First Submitted
February 12, 2008
First Submitted That Met QC Criteria
February 21, 2008
First Posted (ESTIMATE)
February 22, 2008
Study Record Updates
Last Update Posted (ESTIMATE)
March 18, 2013
Last Update Submitted That Met QC Criteria
March 15, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- F0408110045
- U01HL079171 (NIH)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.